These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2585034)

  • 41. Amelioration of adriamycin skin necrosis: an experimental study.
    Cohen MH
    Cancer Treat Rep; 1979 Jun; 63(6):1003-4. PubMed ID: 466641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possibility of Taking an Offensive Stance in Extravasation Injury: Effects of Fat Injection in Vesicant (Doxorubicin) Induced Skin Necrosis Model in Rats.
    Bicer A; Ercin BS; Gürler T; Yiğittürk G; Uyanikgil Y; Cetin EO
    J Invest Surg; 2022 Apr; 35(4):801-808. PubMed ID: 34402353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intradermal carboplatin and ifosfamide extravasation in the mouse.
    Marnocha RS; Hutson PR
    Cancer; 1992 Aug; 70(4):850-3. PubMed ID: 1643617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Stone A
    Cancer Treat Rep; 1985 Apr; 69(4):431-7. PubMed ID: 3995512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer.
    Averbuch SD; Gaudiano G; Koch TH; Bachur NR
    J Clin Oncol; 1986 Jan; 4(1):88-94. PubMed ID: 3941333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies.
    Dahlstrøm KK; Chenoufi HL; Daugaard S
    Cancer; 1990 Apr; 65(8):1722-6. PubMed ID: 2317755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
    Ludwig CU; Stoll HR; Obrist R; Obrecht JP
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in wound healing secondary to infusion injury.
    Larson DL
    Clin Plast Surg; 1990 Jul; 17(3):509-17. PubMed ID: 2199142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early and delayed neurotoxicity of mitoxantrone and doxorubicin following subarachnoid injection.
    Siegal T; Melamed E; Sandbank U; Catane R
    J Neurooncol; 1988 Sep; 6(2):135-40. PubMed ID: 3225635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DMSO protects against adriamycin-induced tissue necrosis.
    Lebredo L; Barrie R; Woltering EA
    J Surg Res; 1992 Jul; 53(1):62-5. PubMed ID: 1405593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
    Storm G; van Hoesel QG; de Groot G; Kop W; Steerenberg PA; Hillen FC
    Cancer Chemother Pharmacol; 1989; 24(6):341-8. PubMed ID: 2791187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitumor agents: extravasation, management, and surgical treatment.
    Scuderi N; Onesti MG
    Ann Plast Surg; 1994 Jan; 32(1):39-44. PubMed ID: 8141535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitomycin C extravasation ulcers.
    Khanna AK; Khanna A; Asthana AK; Misra MK
    J Surg Oncol; 1985 Feb; 28(2):108-10. PubMed ID: 3918215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Hamana H; Uchida N; Maekawa R; Yoshioka T
    Jpn J Cancer Res; 2000 Dec; 91(12):1333-8. PubMed ID: 11123434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.
    Uzunoglu S; Cosar R; Cicin I; Ibis K; Demiralay E; Benlier E; Erdogan B; Kandulu H; Ozen A; Altaner S
    J Plast Surg Hand Surg; 2013 Oct; 47(5):339-43. PubMed ID: 23710793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.